The gross margin trajectory appears consistent with fixed-cost absorption rather than pricing power, since COGS held near $74M while revenue climbed to $116.1M in 2027Q2, echoing the prior income statement finding of flat input costs. Even so, operating expenses of roughly $76.4M still exceed gross profit of $42.3M, so the -30.7% net margin remains the more honest read of current earning power until opex coverage of gross profit improves. Investors should treat the improvement as directionally encouraging but not yet evidence of a durable margin structure.

ROE readings such as -148.8% in 2026Q4 are arithmetically unstable given the shrinking, now-negative equity base identified in the balance sheet work, which makes ROIC the more usable return metric here. The modest improvement from -23.2% in 2026Q4 to -21.0% in 2027Q2 appears margin-driven rather than efficiency-driven, since asset turnover only moved from 0.13 to 0.16 over the same span. On this evidence the company is not yet compounding returns; it is merely reducing the rate of value erosion.

The DSO compression suggests stronger collections or a shift toward more favorable channel terms, and it is the single largest contributor to the CCC improvement. However, DIO rising from 228 to 239 days means inventory remains the dominant working capital claim, so a 206-day cycle still implies cash is committed for roughly two quarters before recovery. Asset turnover of just 0.16 against a specialty-retail peer set that typically turns inventory far faster indicates the working capital profile is structurally demanding rather than temporarily displaced.

Coverage of -129.10x implies interest expense is being serviced from cash reserves rather than operating earnings, which narrows flexibility if losses persist and refinancing is required. The sharp rise in D/E appears, consistent with prior balance sheet analysis, to be driven more by equity erosion than by incremental borrowing, a distinction that matters because the debt amount itself may not be growing. D/E data is unavailable for the three most recent quarters, so the leverage trajectory beyond 2026Q4 cannot be confirmed from these figures and warrants further investigation.

The gap between the 1.07 current ratio and 0.57 quick ratio confirms that current assets are heavily inventory-weighted, consistent with the 239-day DIO, so a demand stumble could convert nominal coverage into a genuine squeeze. Under severe stress, the dependence on converting slow-moving stock into cash within the quarter looks like the key vulnerability rather than any single maturing liability. Combined with the cash decline to $95.3M noted in prior balance sheet work, the position appears adequate only if the revenue recovery observed in 2027 holds.